Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain.
The neurochemical background of the evolution of headache disorders, still remains partially undiscovered. Accordingly, our aim was to further explore the neurochemical profile of Complete Freund's adjuvant (CFA)-induced orofacial pain, involving finding the shift point regarding small molecule...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | JOURNAL OF HEADACHE AND PAIN
21 No. 1 |
| doi: | 10.1186/s10194-020-01105-6 |
| mtmt: | 31303256 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/18732 |
| LEADER | 03042nab a2200313 i 4500 | ||
|---|---|---|---|
| 001 | publ18732 | ||
| 005 | 20200521120220.0 | ||
| 008 | 200521s2020 hu o 0|| zxx d | ||
| 022 | |a 1129-2369 | ||
| 024 | 7 | |a 10.1186/s10194-020-01105-6 |2 doi | |
| 024 | 7 | |a 31303256 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Cseh Edina Katalin | |
| 245 | 1 | 0 | |a Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain. |h [elektronikus dokumentum] / |c Cseh Edina Katalin |
| 260 | |c 2020 | ||
| 300 | |a Azonosító: 35-Terjedelem: 12 p | ||
| 490 | 0 | |a JOURNAL OF HEADACHE AND PAIN |v 21 No. 1 | |
| 520 | 3 | |a The neurochemical background of the evolution of headache disorders, still remains partially undiscovered. Accordingly, our aim was to further explore the neurochemical profile of Complete Freund's adjuvant (CFA)-induced orofacial pain, involving finding the shift point regarding small molecule neurotransmitter concentrations changes vs. that of the previously characterized headache-related neuropeptides. The investigated neurotransmitters consisted of glutamate, γ-aminobutyric acid, noradrenalin and serotonin. Furthermore, in light of its influence on glutamatergic neurotransmission, we measured the level of kynurenic acid (KYNA) and its precursors in the kynurenine (KYN) pathway (KP) of tryptophan metabolism.The effect of CFA was evaluated in male Sprague Dawley rats. Animals were injected with CFA (1 mg/ml, 50 μl/animal) into the right whisker pad. We applied high-performance liquid chromatography to determine the concentrations of the above-mentioned compounds from the trigeminal nucleus caudalis (TNC) and somatosensory cortex (ssCX) of rats. Furthermore, we measured some of these metabolites from the cerebrospinal fluid and plasma as well. Afterwards, we carried out permutation t-tests as post hoc analysis for pairwise comparison.Our results demonstrated that 24 h after CFA treatment, the level of glutamate, KYNA and that of its precursor, KYN was still elevated in the TNC, all diminishing by 48 h. In the ssCX, significant concentration increases of KYNA and serotonin were found.This is the first study assessing neurotransmitter changes in the TNC and ssCX following CFA treatment, confirming the dominant role of glutamate in early pain processing and a compensatory elevation of KYNA with anti-glutamatergic properties. Furthermore, the current findings draw attention to the limited time interval where medications can target the glutamatergic pathways. | |
| 700 | 0 | 1 | |a Veres Gábor |e aut |
| 700 | 0 | 1 | |a Körtési Tamás |e aut |
| 700 | 0 | 1 | |a Polyák Helga |e aut |
| 700 | 0 | 1 | |a Nánási Nikolett |e aut |
| 700 | 0 | 1 | |a Tajti János |e aut |
| 700 | 0 | 1 | |a Párdutz Árpád |e aut |
| 700 | 0 | 1 | |a Klivényi Péter |e aut |
| 700 | 0 | 1 | |a Vécsei László |e aut |
| 700 | 0 | 1 | |a Zádori Dénes |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/18732/1/CsehEdinaK.-Neurotransmitterandtryptophanmetaboliteconcentration.pdf |z Dokumentum-elérés |